Yale New Haven Hospital Receives Transcatheter Valve Center Certification

Monday, March 8, 2021

New Haven, CT (March 8, 2021) – The Structural Heart Program at Yale New Haven Hospital (YNHH) Heart and Vascular Center has received Transcatheter Valve Certification from the American College of Cardiology (ACC).This certification is a recognition of the expertise, quality and safety of care, and outstanding outcomes achieved at YNHH for treating patients who need transcatheter valve replacement. YNHH is the first and only program in Connecticut to receive this certification from the American College of Cardiology.

"We are proud that the Structural Heart Program at Yale New Haven Hospital Heart and Vascular Center is a recipient of ACC Transcatheter Valve Certification,” said John Forrest, MD, director of Structural Heart Program, Yale New Haven Health and associate professor of Medicine, Yale School of Medicine and. “This achievement highlights our talented and experienced team and the quality of care that has come as a result of a multidisciplinary approach to providing evidence-based, patient-centered care in a shared decision making format. As the first center in the state to perform transcatheter aortic valve replacement (TAVR) as well as transcatheter mitral valve repair and replacement, we are committed to providing patients with world-class care from nationally recognized experts in the field."

The Structural Heart Program underwent a rigorous nine-month evaluation in which reviewers from the American College of Cardiology conducted an analysis of key areas including: quality of care, clinical outcomes and patient experience, quality assessment and performance improvement initiatives.

“We are very pleased to have the expertise of our HVC team and quality of our HVC Structural Heart Program validated and certified by the ACC,” said Francine LoRusso, senior vice president operations and executive director, Heart and Vascular Services at YNHH. “This accreditation process and certification further guarantees to our patients that they are receiving exceptional, evidence-based care with high quality outcomes. We are grateful for the talent and leadership of Dr. Forrest and the extraordinary Heart and Vascular Center staff who contribute to this care on a daily basis.”

The certification is based on established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification learn and use best practices for implementing evidence-based medicine to support patient-shared decision-making and can track key performance metrics to better identify opportunities for improvement.

The certification is valid for three years and is effective through February 2024.

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties.

Similar Articles


Yale New Haven Health announces it is now administering COVID-19 dose 3 and boosters

New Haven, CT (Sept. 24, 2021) – Yale New Haven Health System (YNHHS) today announced that it has begun offering booster and dose three vaccinations at select sites across the state.


Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.


Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.